摘要
目的观察黄芩苷联合苦参素治疗慢性乙型肝炎的临床疗效。方法治疗组:黄芩苷片每次0.75g,每日3次口服,联合苦参素胶囊每次0.2g,每日3次口服,26周为一个疗程,治疗慢性乙型肝炎患者35例;观察组:随机抽取另外35例慢性乙型肝炎患者,予苦参素胶囊治疗,每次0.2g,每日3次口服,26周为一个疗程,对照观察疗效。结果黄芩苷联合苦参素治疗组临床症状改善明显,降低ALT、AST、γ-GT、T.Bil,与治疗前比较差异有显著性,与对照组比较差异有显著性(P<0.05或0.01)。结论黄芩苷联合苦参素具有明显改善慢性乙型肝炎的临床症状,降低转氨酶,改善肝功能的作用。
Objective To observe the therapeutic effect of combined baicalin with oxymatrine on chronic hepatitis B. Methods Combined 0.75 gram of baicalin with 0.2 gram of oxymatrine,three times per day for 26 weeks,35 patients of chronic hepatitis B were treated and compared with 35 patients,which were selected randomly and treated with 0.2 gram of oxymatrine,three times per day for 26 weeks. Results The combined baicalin with oxymatrine group could improve the clinical syndromes of patients, decrease significantly serum ALT, AST, γ-GT, T. Bil,comparing to contrast group the differentiation had obviously significance（P〈 0.05 or 0.01 ）. Conclusion The results indicate that therapeutic method of combined baicalin with oxymatrine may improve the clinical syndromes of chronic hepatitis B, reduce aminopherase, regulate the liver＇s metabolic function, antifirosis of liver.
出处
《中国现代医生》
2008年第29期8-9,11,共3页
China Modern Doctor
